middle.news

How IDT’s Strategic Reset Sparked 20% Revenue Growth and Slashed Losses

10:32am on Wednesday 18th of February, 2026 AEDT Pharmaceuticals
Read Story

How IDT’s Strategic Reset Sparked 20% Revenue Growth and Slashed Losses

10:32am on Wednesday 18th of February, 2026 AEDT
Key Points
  • Core revenue up 20.3% to $8.4 million
  • EBITDA loss reduced from $2.7 million to $436k
  • Operating expenses cut by $1.1 million (14.2%)
  • API manufacturing revenue surges 191.4% to $3 million
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about IDT AUSTRALIA (ASX:IDT)
OPEN ARTICLE